Godshalk Welsh Capital Management, Inc. Amgen Inc Transaction History
Godshalk Welsh Capital Management, Inc.
- $152 Million
- Q4 2024
A detailed history of Godshalk Welsh Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Godshalk Welsh Capital Management, Inc. holds 1,170 shares of AMGN stock, worth $363,612. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,170
Previous 1,145
2.18%
Holding current value
$363,612
Previous $368,000
17.39%
% of portfolio
0.2%
Previous 0.24%
Shares
5 transactions
Others Institutions Holding AMGN
# of Institutions
3,173Shares Held
419MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.15 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.52 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.1 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $166B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...